Allermi

About

Allermi is a direct-to-consumer telehealth company focused on personalized allergy care. Co-founded in 2022 by Shani Bocian and Dr. Robert Bocian, a seasoned allergist, Allermi aims to meet the needs of individuals suffering from allergies through customized solutions. The company has received $3.5 million in seed funding to expand its services across the United States. Allermi operates a telehealth platform that connects patients with board-certified allergists for personalized consultations. It offers a unique product: a customized nasal spray designed to address specific allergy symptoms. This spray combines multiple active ingredients tailored to each patient's needs, based on Dr. Bocian's research. Allermi targets the 110 million Americans affected by allergies, providing a patient-centric approach that simplifies access to specialized care.